|
|
|
|
|
|
by mft_
781 days ago
|
|
|
Almost certainly not below cost. And the US isn't paying for the R&D (that sounds like a regurgitated line from somewhere?) so much as paying for the pharma company's profits, due to the US's totally screwed-up healthcare system and situation. |
|
|